{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T20:18:49Z","timestamp":1786997929846,"version":"build-2736575974"},"reference-count":24,"publisher":"Elsevier BV","issue":"32","license":[{"start":{"date-parts":[[2012,7,1]],"date-time":"2012-07-01T00:00:00Z","timestamp":1341100800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2012,7]]},"DOI":"10.1016\/j.vaccine.2012.04.032","type":"journal-article","created":{"date-parts":[[2012,4,23]],"date-time":"2012-04-23T18:56:59Z","timestamp":1335207419000},"page":"4884-4891","source":"Crossref","is-referenced-by-count":41,"title":["Bacterium-like particles supplemented with inactivated influenza antigen induce cross-protective influenza-specific antibody responses through intranasal administration"],"prefix":"10.1016","volume":"30","author":[{"given":"Aalzen","family":"de Haan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bert Jan","family":"Haijema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra","family":"Voorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tjarko","family":"Meijerhof","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maarten L.","family":"van Roosmalen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kees","family":"Leenhouts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.vaccine.2012.04.032_bib0005","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1002\/eji.1830140414","article-title":"Cross-protection in mice infected with influenza A virus by the respiratory route is correlated with local IgA antibody rather than serum antibody or cytotoxic T cell reactivity","volume":"14","author":"Liew","year":"1984","journal-title":"European Journal of Immunology"},{"issue":"11","key":"10.1016\/j.vaccine.2012.04.032_bib0010","doi-asserted-by":"crossref","first-page":"6883","DOI":"10.4049\/jimmunol.0901466","article-title":"What role does the route of immunization play in the generation of protective immunity against mucosal pathogens?","volume":"183","author":"Belyakov","year":"2009","journal-title":"Journal of Immunology"},{"issue":"1","key":"10.1016\/j.vaccine.2012.04.032_bib0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/10611860701637966","article-title":"Rational design of nasal vaccines","volume":"16","author":"Slutter","year":"2008","journal-title":"Journal of Drug Targeting"},{"issue":"15","key":"10.1016\/j.vaccine.2012.04.032_bib0020","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1016\/j.vaccine.2004.11.009","article-title":"Immune response versus mucosal tolerance to mucosally administered antigens","volume":"23","author":"Mestecky","year":"2005","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2012.04.032_bib0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-3083.2009.02321.x","article-title":"Mucosally induced immunological tolerance, regulatory T cells and the adjuvant effect by cholera toxin B subunit","volume":"71","author":"Sun","year":"2010","journal-title":"Scandinavian Journal of Immunology"},{"issue":"19\u201320","key":"10.1016\/j.vaccine.2012.04.032_bib0030","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1016\/S0264-410X(02)00155-X","article-title":"A dilemma for mucosal vaccination: efficacy versus toxicity using enterotoxin-based adjuvants","volume":"20","author":"Fujihashi","year":"2002","journal-title":"Vaccine"},{"issue":"9","key":"10.1016\/j.vaccine.2012.04.032_bib0035","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1056\/NEJMoa030595","article-title":"Use of the inactivated intranasal influenza vaccine and the risk of Bell's palsy in Switzerland","volume":"350","author":"Mutsch","year":"2004","journal-title":"New England Journal of Medicine"},{"issue":"2","key":"10.1016\/j.vaccine.2012.04.032_bib0040","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.ymeth.2005.09.015","article-title":"Mucosal vaccine delivery of antigens tightly bound to an adjuvant particle made from food-grade bacteria","volume":"38","author":"van Roosmalen","year":"2006","journal-title":"Methods"},{"issue":"26","key":"10.1016\/j.vaccine.2012.04.032_bib0045","doi-asserted-by":"crossref","first-page":"5434","DOI":"10.1016\/j.vaccine.2006.03.054","article-title":"Lactococcus lactis GEM particles displaying pneumococcal antigens induce local and systemic immune responses following intranasal immunization","volume":"24","author":"Audouy","year":"2006","journal-title":"Vaccine"},{"issue":"13","key":"10.1016\/j.vaccine.2012.04.032_bib0050","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1016\/j.vaccine.2006.09.026","article-title":"Development of lactococcal GEM-based pneumococcal vaccines","volume":"25","author":"Audouy","year":"2007","journal-title":"Vaccine"},{"issue":"18","key":"10.1016\/j.vaccine.2012.04.032_bib0055","doi-asserted-by":"crossref","first-page":"3900","DOI":"10.1016\/j.vaccine.2006.02.040","article-title":"Immunogenicity of a malaria parasite antigen displayed by Lactococcus lactis in oral immunisations","volume":"24","author":"Ramasamy","year":"2006","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2012.04.032_bib0060","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/mi.2009.131","article-title":"Neonatal mucosal immunization with a non-living, non-genetically modified Lactococcus lactis vaccine carrier induces systemic and local Th1-type immunity and protects against lethal bacterial infection","volume":"3","author":"Ramirez","year":"2010","journal-title":"Mucosal Immunology"},{"issue":"2","key":"10.1016\/j.vaccine.2012.04.032_bib0065","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1208\/s12248-009-9168-2","article-title":"Intranasal delivery of influenza subunit vaccine formulated with GEM particles as an adjuvant","volume":"12","author":"Saluja","year":"2010","journal-title":"AAPS Journal"},{"issue":"3","key":"10.1016\/j.vaccine.2012.04.032_bib0075","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0092-1157(77)80008-5","article-title":"An improved single-radial-immunodiffusion technique for the assay of influenza haemagglutinin antigen: application for potency determinations of inactivated whole virus and subunit vaccines","volume":"5","author":"Wood","year":"1977","journal-title":"Journal of Biological Standardization"},{"issue":"20\u201322","key":"10.1016\/j.vaccine.2012.04.032_bib0080","doi-asserted-by":"crossref","first-page":"2898","DOI":"10.1016\/S0264-410X(00)00556-9","article-title":"Nasal or intramuscular immunization of mice with influenza subunit antigen and the B subunit of Escherichia coli heat-labile toxin induces IgA- or IgG-mediated protective mucosal immunity","volume":"19","author":"Haan","year":"2001","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2012.04.032_bib0085","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.4049\/jimmunol.146.6.1972","article-title":"Passive transfer of local immunity to influenza virus infection by IgA antibody","volume":"146","author":"Renegar","year":"1991","journal-title":"Journal of Immunology"},{"issue":"4","key":"10.1016\/j.vaccine.2012.04.032_bib0090","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1128\/JVI.65.4.2146-2148.1991","article-title":"Immunoglobulin A mediation of murine nasal anti-influenza virus immunity","volume":"65","author":"Renegar","year":"1991","journal-title":"Journal of Virology"},{"issue":"50","key":"10.1016\/j.vaccine.2012.04.032_bib0095","doi-asserted-by":"crossref","first-page":"7963","DOI":"10.1016\/j.vaccine.2010.09.066","article-title":"Influenza antigen-sparing by immune stimulation with Gram-positive enhancer matrix (GEM) particles","volume":"28","author":"Saluja","year":"2010","journal-title":"Vaccine"},{"issue":"9","key":"10.1016\/j.vaccine.2012.04.032_bib0100","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1128\/CVI.00156-06","article-title":"Distinct contributions of vaccine-induced immunoglobulin G1 (IgG1) and IgG2a antibodies to protective immunity against influenza","volume":"13","author":"Huber","year":"2006","journal-title":"Clinical and Vaccine Immunology"},{"issue":"3","key":"10.1016\/j.vaccine.2012.04.032_bib0105","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.ejpb.2010.08.003","article-title":"Gastro-intestinal delivery of influenza subunit vaccine formulation adjuvanted with Gram-positive enhancer matrix (GEM) particles","volume":"76","author":"Saluja","year":"2010","journal-title":"European Journal of Pharmaceutics and Biopharmaceutics"},{"issue":"10","key":"10.1016\/j.vaccine.2012.04.032_bib0110","doi-asserted-by":"crossref","first-page":"6308","DOI":"10.4049\/jimmunol.174.10.6308","article-title":"The mucosal adjuvant macrophage-activating lipopeptide-2 directly stimulates B lymphocytes via the TLR2 without the need of accessory cells","volume":"174","author":"Borsutzky","year":"2005","journal-title":"Journal of Immunology"},{"issue":"1","key":"10.1016\/j.vaccine.2012.04.032_bib0115","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.clim.2010.09.003","article-title":"Toll-like receptor 2 induces mucosal homing receptor expression and IgA production by human B cells","volume":"138","author":"Liang","year":"2011","journal-title":"Clinical Immunology"},{"issue":"2\u20133","key":"10.1016\/j.vaccine.2012.04.032_bib0120","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.molimm.2009.09.007","article-title":"Transcriptional analysis of Toll-like receptors expression in M cells","volume":"47","author":"Cashman","year":"2009","journal-title":"Molecular Immunology"},{"issue":"29","key":"10.1016\/j.vaccine.2012.04.032_bib0125","doi-asserted-by":"crossref","first-page":"5348","DOI":"10.1016\/j.vaccine.2007.05.029","article-title":"TLR2 activation by proteosomes promotes uptake of particulate vaccines at mucosal surfaces","volume":"25","author":"Chabot","year":"2007","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X12005634?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X12005634?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,22]],"date-time":"2023-06-22T02:46:33Z","timestamp":1687401993000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X12005634"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7]]},"references-count":24,"journal-issue":{"issue":"32","published-print":{"date-parts":[[2012,7]]}},"alternative-id":["S0264410X12005634"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2012.04.032","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,7]]}}}